H.R. 5839 · 110th Congress
Safeguarding America's Pharmaceuticals Act of 2008
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 110th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
BuyerSponsor12 cosponsors · 5 D, 7 R
D
Green
JM
D
Matheson
MR
R
Rogers
BB
R
Bilbray
MF
R
Ferguson
RB
R
Bartlett
DH
R
Hunter
SJ
D
Jackson Lee
JW
R
Wilson
WJ
D
Jefferson
KM
D
Meek
MS
R
Souder3 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Safeguarding America's Pharmaceuticals Act of 2008 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of the Treasury to destroy imported counterfeit drugs and certain adulterated or misbranded imported drugs.
What it does: CRS summary · Introduced in House · Apr 17, 2008
Safeguarding America's Pharmaceuticals Act of 2008 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of the Treasury to destroy imported counterfeit drugs and certain adulterated or misbranded imported drugs.
Requires the manufacturer of a prescription drug to provide to each wholesale distributor or dispenser a packing list or comparable document that includes information identifying the drug's proprietary and established names and National Drug Code number.
Requires each person engaged in wholesale distribution of a prescription drug to provide information on each prior transaction involving the drug.
Requires the Secretary of Health and Human Services (the Secretary) to report to Congress on the feasibility and operational efficiencies of adopting security technologies, including track and trace technology throughout the prescription drug supply chain. Phases in requirements for standardized numerical identifiers that are unique to each unit of a prescription drug.
Requires the Secretary to issue regulations to establish an effective drug identification and tracking system to authenticate the wholesale distribution history of any prescription drug that is subject to a requirement for such an identifier.
Requires the Comptroller General to study the availability and cost of technologies to dispensers to comply with this Act.
Requires the Secretary to: (1) award matching grants for drug identification and tracking systems to ensure the security and integrity of the drug supply chain; and (2) issue guidelines for wholesale distributors that prescribe requirements that include mandatory background checks and physical inspection of facilities.
Sets forth civil penalties for violations of this Act.
Requires the Secretary to study threats to the domestic prescription drug supply chain and make recommendations for improvements.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Safeguarding America's Pharmaceuticals Act of 2008
Latest action (Apr 17, 2008): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Apr 17, 2008
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.